The Enzyme That Stops DNA Production When Cells Have Enough: Unveiling the Role of NUDT5
The Intricate Balance of Cellular Metabolism
Within the intricate world of cells, a delicate metabolic network orchestrates the production, recycling, and cessation of essential molecules. At the heart of this network lies folate metabolism, a process that provides the building blocks for DNA, RNA, and amino acids. When this system is disrupted, whether by genetic mutations or dietary deficiencies, the consequences can be severe, ranging from developmental disorders to cancer.
In a groundbreaking discovery, researchers from CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in collaboration with the University of Oxford, have identified a surprising player in this metabolic balance: the enzyme NUDT5. Their study, published in Science, reveals that NUDT5 plays a crucial role in shutting down purine production, the chemical pathway responsible for DNA building blocks, but it does so without using its enzymatic activity. Instead, NUDT5 acts as a molecular scaffold, physically restraining a key biosynthetic step when purine levels are already high.
A New Role for an Old Enzyme
Purines are essential molecules that cells utilize for DNA and RNA synthesis and energy storage. They can be recycled from existing materials or synthesized de novo through an energy-intensive process that demands tight control. The researchers explored this control mechanism by studying cells with mutations in the gene MTHFD1, a critical enzyme in the folate cycle. Folate metabolism provides the one-carbon units required for purine synthesis, and defects in this pathway can lead to rare genetic diseases and influence cancer risk.
Through a combination of genetic screening, metabolomics, and chemical biology, the team uncovered that NUDT5 interacts with another enzyme, PPAT, which catalyzes the first step of purine synthesis. When purine levels rise, NUDT5 binds to PPAT, likely locking it into an inactive form, signaling the cell to cease purine production.
Surprisingly, NUDT5's regulatory function does not rely on its known enzymatic activity, which breaks down nucleotide derivatives. Even when its catalytic site was chemically blocked or genetically disabled, NUDT5 continued to regulate purine synthesis. It was only when NUDT5 was completely removed, either through genetic knockout or a novel molecule that selectively degrades it, that cells lost this control mechanism.
Metabolic Control with Medical Implications
This discovery sheds new light on how cells sense and respond to metabolic changes. Stefan Kubicek, Principal Investigator at CeMM and senior author of the study, explains that NUDT5 has long been classified as an enzyme that hydrolyzes metabolites. However, their research reveals a different role: NUDT5 acts as a structural regulator, determining whether cells continue producing purines or not.
This mechanism may also explain the resistance of some cells to cancer drugs. Many chemotherapies, such as 6-thioguanine, work by mimicking purine molecules and blocking DNA synthesis. The study found that cells without functional NUDT5-PPAT interaction were less sensitive to these treatments, suggesting that mutations in NUDT5 could contribute to drug resistance in tumors. This finding is supported by similar research from Ralph DeBerardinis' laboratory, also published in Science. The key role of NUDT5 in controlling cancer drug sensitivity is further emphasized.
Additionally, the research connects folate metabolism, purine synthesis, and diseases caused by MTHFD1 deficiency, a rare genetic disorder affecting immune and neurological development. Understanding this regulatory network could lead to new therapeutic approaches, as the folate and purine pathways are closely linked.
The collaborators in Kilian Huber's lab at Oxford developed a chemical degrader called dNUDT5, which can selectively eliminate NUDT5 from cells. This tool will enable scientists to study the pathway in more detail and may offer future possibilities for protecting healthy cells from chemotherapy side effects.
In conclusion, the study highlights that enzymes can act through their structure, not just chemical reactions. The physical presence of a protein can make a crucial difference, as revealed by the unique role of NUDT5 in cellular metabolism.
